has been cited by the following article(s):
[1]
|
Third trimester re‐screening for gestational diabetes in morbidly obese women despite earlier negative test can reveal risks for obstetrical complications
Journal of Obstetrics and Gynaecology Research,
2023
DOI:10.1111/jog.15515
|
|
|
[2]
|
Third trimester re‐screening for gestational diabetes in morbidly obese women despite earlier negative test can reveal risks for obstetrical complications
Journal of Obstetrics and Gynaecology Research,
2022
DOI:10.1111/jog.15515
|
|
|
[3]
|
Obstetrical Outcome following Diagnosis of Gestational Diabetes in the Third Trimester (>29 Weeks) versus Second Trimester (24–28 Weeks): A Retrospective Comparative Study
American Journal of Perinatology,
2022
DOI:10.1055/s-0042-1759865
|
|
|